Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2024

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		*June 30, 2024*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Net Carrying Amount*
Developed technology		$	2,310			$	(453	)		$	1,857
Trade name			2,310				N/A				2,310
Intellectual property			460				—				460
Customer relationships			140				(28	)			112
Total intangible assets		$	5,220			$	(481	)		$	4,739

		*December 31, 2023*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Net Carrying Amount*
Developed technology		$	2,310			$	(310	)		$	2,000
Trade name			2,310				N/A				2,310
Intellectual property			460				—				460
Customer relationships			140				(18	)			122
Total intangible assets		$	5,220			$	(328	)		$	4,892

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2024 - remainder		$	153
2025			345
2026			345
2027			345
2028			345
2029 and thereafter			896
Total		$	2,429